Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

AstraZeneca and Merck & Co's Lynparza has been the undisputed market ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial ...

GSK's chief commercial officer Luke Miels said on the ... and AZ's PARP inhibitor Lynparza (olaparib), but that was not included in the FDA's decision. Just as for previous schemes, metrics ...

The company’s key drugs like Lynparza, Tagrisso ... AT&T intends to leverage Ericsson technology to deploy a commercial-scale open radio access network across the country to help build a ...

The company's key drugs like Lynparza, Tagrisso ... AT&T intends to leverage Ericsson technology to deploy a commercial-scale open radio access network across the country to help build a more ...

Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

The drugmaker emphasized plans to move further away from singular reliance on Keytruda while reporting solid sales growth in ...